메뉴 건너뛰기
Chest
Volumn 128, Issue 1, 2005, Pages 471-472
Low-molecular-weight heparin and outcomes [9] (multiple letters)
Author keywords

[No Author keywords available]
Indexed keywords

CERTOPARIN; DALTEPARIN; DNA TOPOISOMERASE; ENDOTHELIAL CELL GROWTH FACTOR; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RNA DIRECTED DNA POLYMERASE; SELECTIN; TELOMERASE; TINZAPARIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN;
EID: 22244449630     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.471     Document Type: Letter
Times cited : (2)
References (5)
  • 1
    • 1842463681 scopus 로고    scopus 로고
    • Antimetastatic effect of tinzaparin, a low-molecular-weight heparin
    • A Amirkhosravi SA Mousa M Amaya Antimetastatic effect of tinzaparin, a low-molecular-weight heparin J Thromb Haemost 1 2003 1972 1976
    • (2003) J Thromb Haemost , vol.1 , pp. 1972-1976
    • Amirkhosravi, A1    Mousa, SA2    Amaya, M3
  • 2
    • 14744305444 scopus 로고    scopus 로고
    • Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy
    • SA Mousa S Mohamed Antiangiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy Oncol Rep 12 2004 683 688
    • (2004) Oncol Rep , vol.12 , pp. 683-688
    • Mousa, SA1    Mohamed, S2
  • 3
    • 0034164514 scopus 로고    scopus 로고
    • Effect of low-molecular weight heparin (certoparin) versus unfractionated heparin on cancer following breast and pelvic cancer surgery: a prospective randomized double-blind trial
    • GF Von Tempelhoff J Harenberg F Nieman Effect of low-molecular weight heparin (certoparin) versus unfractionated heparin on cancer following breast and pelvic cancer surgery: a prospective randomized double-blind trial Int J Oncol 16 2000 815 824
    • (2000) Int J Oncol , vol.16 , pp. 815-824
    • Von Tempelhoff, GF1    Harenberg, J2    Nieman, F3
  • 4
    • 12844289104 scopus 로고    scopus 로고
    • A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
    • M Altinbas HS Coskun O Er A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer J Thromb Haemost 2 2004 1266 1271
    • (2004) J Thromb Haemost , vol.2 , pp. 1266-1271
    • Altinbas, M1    Coskun, HS2    Er, O3
  • 5
    • 3042704507 scopus 로고    scopus 로고
    • Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS)
    • AK Kakkar MN Levine Z Kadziola Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS) J Clin Oncol 22 2004 1944 1948
    • (2004) J Clin Oncol , vol.22 , pp. 1944-1948
    • Kakkar, AK1    Levine, MN2    Kadziola, Z3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.